COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Levomilnacipran in Healthy Males

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03249311
Recruitment Status : Recruiting
First Posted : August 15, 2017
Last Update Posted : April 17, 2019
Information provided by (Responsible Party):
Pierre Blier, University of Ottawa

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 31, 2019
Estimated Study Completion Date : January 31, 2020
Blier, P., Aldosary, F., Tremblay, P., & Hébert, C. (2010). Inhibition of norepinephrine and serotonin reuptake by venlafaxine, paroxetine and atomoxetine in depressed patients. Int J Neuropsychopharmacol 13(Suppl 1):143S.
First, M.B., Williams, J.B.W., Karg, R.S., & Spitzer, R.L. (2015). Structured clinical interview for DSM-5-research version. Arlington: American Psychiatric Association.